Japan’s RaQualia Pharma (TYO: 4579) has announced the termination of the license agreement regarding a retinoic acid receptor ...

US gastrointestinal (GI) and rare diseases specialist Ironwood Pharmaceuticals (Nasdaq: IRWD) was trading 34% lower early ...

US pharma giant Pfizer has announced that it is discontinuing development of danuglipron (PF-06882961), an oral glucagon-like ...

A Texan drug compounder cannot rely on federal law to avoid a lawsuit over copycat sales of a rheumatoid arthritis treatment, ...

According to the country’s trade group LIF, Sweden must be a driving force in the European Union (EU) to ensure that ...

The European Commission has approved Columvi (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for the ...

The Dutch Healthcare Authority (NZa) has published a report entitled From patent to competition – Analysis of expenditure and ...

Shares in US biotech Novavax fell more than 20% before the weekend, following remarks from health and human services ...

Japanese biotech Prism BioLab has entered a strategic partnership with AI drug discovery company Elix to accelerate the ...

Swiss generic and biosimilar medicines firm Sandoz (SIX: SDZ) today announced it has filed an antitrust lawsuit in the USA ...

Belgium’s largest pharma company, has announced findings from a collection of real-world evidence studies to reaffirm the ...

Shares of California-based Coherus BioSciences (Nasdaq: CHRS) rose more than 5% to $0.88 in pre-market activity today as it ...